AEHR (AEHR) director’s trust sells 3,000 shares, retains over 20,000

Rhea-AI Filing Summary

AEHR TEST SYSTEMS director Laura Oliphant reported an open-market sale of common stock by a trust associated with her. The trust sold 3,000 shares of AEHR common stock at a price of $68.3575 per share on April 9, 2026. After this transaction, the trust continued to hold 4,665 shares indirectly. Separately, Oliphant also reported direct ownership of 18,432 shares of common stock, some of which are subject to unvested restricted stock units.

Insights

Equity compensation and insider-trading analyst

Director-related trust sold 3,000 AEHR shares while sizable holdings remain.

The filing shows a trust associated with director Laura Oliphant executed an open-market sale of 3,000 AEHR TEST SYSTEMS common shares at $68.3575. This is a straightforward secondary-market sale, not tied to an option exercise or derivative conversion.

Post-transaction, the trust still holds 4,665 shares indirectly, and Oliphant reports an additional 18,432 shares held directly, including shares subject to unvested restricted stock units. The available data suggests a partial reduction in holdings rather than a full exit, and the event appears routine in nature based solely on this information.

Insider Trade Summary

Net Seller: 3,000 shares ($205,073)

Net Sell 2 txns

Insider OLIPHANT LAURA

Role Director

Sold 3,000 shs ($205K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,000	$68.3575	$205K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 4,665 shares (Indirect, By Trust); Common Stock — 18,432 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 3,000 shares Sale price per share: $68.3575 per share Indirect holdings after sale: 4,665 shares +1 more

4 metrics

Shares sold 3,000 shares Open-market sale by associated trust on April 9, 2026

Sale price per share $68.3575 per share Price for 3,000 AEHR common shares sold

Indirect holdings after sale 4,665 shares Shares held indirectly by trust following transaction

Direct holdings after transaction 18,432 shares Shares held directly by Laura Oliphant, includes unvested RSUs

Key Terms

open-market sale, restricted stock units, indirect ownership, Form 4

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

restricted stock units financial

"The amount reported includes shares subject to unvested restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

indirect ownership financial

"direct_or_indirect: "I" and nature_of_ownership: "By Trust""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OLIPHANT LAURA

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CALIFORNIA 94539

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/09/2026		S		3,000	D	$68.3575	4,665	I	By Trust
Common Stock								18,432(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AEHR director Laura Oliphant report?

Director Laura Oliphant reported an open-market sale of 3,000 AEHR Test Systems common shares by a trust associated with her at $68.3575 per share. This is disclosed as a non-derivative transaction in common stock dated April 9, 2026, under a Form 4 filing.

At what price were the AEHR shares sold in Laura Oliphant’s Form 4?

The 3,000 AEHR Test Systems common shares were sold at $68.3575 per share. This price reflects the average sale price reported for the open-market transaction executed on April 9, 2026, as disclosed in the Form 4 insider trading report.

How many AEHR shares does Laura Oliphant report owning after the sale?

After the reported sale, a trust associated with Laura Oliphant holds 4,665 AEHR shares indirectly, and she also reports 18,432 shares held directly. The direct holdings include shares subject to unvested restricted stock units, according to the footnote in the Form 4 filing.

Is Laura Oliphant’s AEHR share sale a direct or indirect transaction?

The 3,000-share sale is reported as an indirect transaction, with ownership described as “By Trust.” This means the shares were held and sold through a trust associated with Laura Oliphant, rather than from her directly held share account, as specified in the Form 4 details.

Does Laura Oliphant still hold AEHR shares following the reported sale?

Yes. Following the transaction, the trust associated with Laura Oliphant holds 4,665 AEHR shares indirectly, and she also reports 18,432 shares held directly. A footnote explains that the reported amount includes shares subject to unvested restricted stock units, indicating continuing equity exposure.